Philippe Schaison

Dr. Schaison is a CEO, CCO and Global President, in consumer healthcare, consumer goods & retail sectors (Asia, South America & Europe) with experience running a $2.5B+ business growing 17% a year (Allergan), acquiring/integrating a +$2B organization, and successfully leading global organizations. His communication/interpersonal skills & ability to work effectively with boards/senior executives and build/lead high-performance teams has informed all his work.

Hired as CEO of Syneron-Candela NA to take the publicly-traded company (ELOS) private, Dr. Schaison sold the company to Private Equity firm Apax in July 2017. Earlier, as Allergan President, US Aesthetic & Dermatology, Dr. Schaison led the Facial Aesthetic, Plastic and MedDerm/Skin Medical Business Unit Presidents. He secured market leadership for Botox and led the acquisition of Kythera.

Previously, Dr. Schaison was President, Clarins Worldwide Travel Retail & Regional President, LATAM and MEA, CEO of Aesthetic Factors, and VP of Global Skin Care for Johnson & Johnson. He sits on the Board of Directors for many companies, including SENTE, Sientra, Dyve Biosciences, and the Galien Foundation.

Dr. Schaison earned an MBA from the Hautes Etudes Commerciales, and a Doctorate in Pharmacy from the University of Paris V.